Recent advances in folic acid engineered nanocarriers for treatment of breast cancer

Volume: 56, Pages: 101613 - 101613
Published: Apr 1, 2020
Abstract
Breast cancer is one of the most prevalent types of cancer among female patients, which is caused by mutations in the oestrogen/progesterone receptors. Conventional treatment methods are generally used for eradication of cancer; however, it has been associated with numerous adverse effects which emerge the need of nanotechnology in cancer therapy. This review is focused on nanotechnology based-therapeutic approaches increasingly acceptable to...
Paper Details
Title
Recent advances in folic acid engineered nanocarriers for treatment of breast cancer
Published Date
Apr 1, 2020
Volume
56
Pages
101613 - 101613
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.